Rare disease drugs will be consigned for manufacturing by domestic pharmaceutical companies

Domestic pharmaceutical companies will be able to consign manufacturing of rare disease drugs and pharmaceutical products that are promptly required to be introduced in Korea.

On the 24^th, the Ministry of Food and Drug Safety gave an administrative notice of the Amendment to the Pharmaceutical Affairs Law, containing an article to allow pharmaceutical companies to consign manufacturing of phar...